Xenon Pharmaceuticals Inc. (XENE) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Xenon Pharmaceuticals Inc. (XENE) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

XENE Income Statement

Xenon Pharmaceuticals Inc. (XENE) annual income statement — 14-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	7.5M	0	0	0	0	0	0	0	0	0	132K	536K	8.77M	3.74M	8.12M
Revenue Growth %	-	-100%	-	-	-	-	-	-	-	-	-	-100%	-100%	-100%	-100%	-98.38%	-75.83%	101.15%	-27.44%	23.95%
Cost of Goods Sold	0	0	611K	77.05M	632K	0	0	0	0	599K	0	0	0	0	0	29.43M	22.15M	19.36M	21.89M	18.89M
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	22296.21%	4131.72%	220.85%	585.68%	232.53%
Gross Profit	0	0	-611K	-77.05M	-632K	7.5M	0	0	0	-599K	0	0	0	0	0	-29.3M	-21.61M	-10.59M	-18.15M	-10.77M
Gross Margin %	-	-	-	-	-	100%	-	-	-	-	-	-	-	-	-	-22196.21%	-4031.72%	-120.85%	-485.68%	-132.53%
Gross Profit Growth %	100%	-100%	-	-	-	1352.09%	-	-	-	-	-	100%	100%	100%	100%	-172.12%	-33.73%	11.35%	-84.88%	-264.28%
Operating Expenses	123.16M	112.33M	109.16M	19.28M	93.6M	80.24M	77.48M	73.68M	69.1M	58.44M	53.7M	55.68M	55.62M	49.05M	43.33M	8.83M	8.71M	6.78M	6.69M	4.83M
OpEx % of Revenue	-	-	-	-	-	1069.84%	-	-	-	-	-	-	-	-	-	6688.64%	1624.07%	77.29%	178.97%	59.47%
Selling, General & Admin	23.93M	23.82M	22.07M	19.28M	19.24M	19.04M	18M	16.71M	19.4M	14.19M	12.62M	12.8M	11.58M	9.54M	8.5M	8.83M	8.71M	6.78M	6.69M	4.83M
SG&A % of Revenue	-	-	-	-	-	253.84%	-	-	-	-	-	-	-	-	-	6688.64%	1624.07%	77.29%	178.97%	59.47%
Research & Development	99.22M	88.51M	87.7M	77.05M	74.98M	61.2M	59.47M	56.97M	49.7M	44.25M	41.08M	42.88M	44.04M	39.52M	34.83M	29.43M	22.15M	19.36M	21.89M	18.89M
R&D % of Revenue	-	-	-	-	-	816%	-	-	-	-	-	-	-	-	-	22296.21%	4131.72%	220.85%	585.68%	232.53%
Other Operating Expenses	0	0	-611K	-1000K	-632K	0	0	0	0	0	0	0	0	0	0	-1000K	-1000K	-1000K	-1000K	-1000K
Operating Income	-123.16M	-112.33M	-109.77M	-96.34M	-94.23M	-72.74M	-77.48M	-73.68M	-69.1M	-59.04M	-53.7M	-55.68M	-55.62M	-49.05M	-43.33M	-38.13M	-30.32M	-17.37M	-24.84M	-15.6M
Operating Margin %	-	-	-	-	-	-969.84%	-	-	-	-	-	-	-	-	-	-28884.85%	-5655.78%	-198.14%	-664.65%	-192%
Operating Income Growth %	-30.7%	-54.43%	-41.68%	-30.76%	-36.36%	-23.2%	-44.29%	-32.31%	-24.23%	-20.37%	-23.92%	-46.04%	-83.49%	-182.41%	-74.45%	-144.44%	-34.75%	-8.16%	-92.2%	-60.82%
EBITDA	-111.32M	-111.74M	-109.16M	-95.69M	-93.6M	-72.08M	-76.84M	-72.98M	-68.46M	-58.44M	-52.84M	-53.95M	-55.02M	-48.7M	-42.82M	-37.77M	-29.94M	-16.99M	-24.57M	-15.39M
EBITDA Margin %	-	-	-	-	-	-961.05%	-	-	-	-	-	-	-	-	-	-28613.64%	-5585.82%	-193.85%	-657.43%	-189.43%
EBITDA Growth %	-18.94%	-55.03%	-42.05%	-31.13%	-36.71%	-23.33%	-45.42%	-35.27%	-24.43%	-20.01%	-23.42%	-42.84%	-83.77%	-186.57%	-74.28%	-145.44%	-34.46%	-7.12%	-93.13%	-61.51%
D&A (Non-Cash Add-back)	0	587K	611K	641K	632K	659K	633K	700K	641K	599K	851K	1.73M	602K	354K	515K	358K	375K	376K	270K	209K
EBIT	-111.32M	-112.33M	-104.72M	-90.22M	-94.23M	-72.74M	-77.48M	-73.68M	-69.1M	-59.04M	-53.7M	-55.68M	-55.62M	-49.05M	-39.44M	-38.13M	-30.32M	-17.37M	-24.84M	-15.6M
Net Interest Income	12.14M	6.91M	6.21M	6.21M	7.2M	8.08M	9.42M	10.33M	10.84M	11.36M	8.69M	6.98M	6.52M	5.42M	4.46M	3.07M	816K	368K	263K	57K
Interest Income	12.14M	6.91M	6.21M	6.21M	7.2M	8.08M	9.42M	10.33M	10.84M	11.36M	8.69M	6.98M	6.52M	5.42M	4.46M	3.07M	816K	368K	263K	76K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19K
Other Income/Expense	11.83M	7.46M	5.04M	6.12M	8.9M	8.12M	7.94M	10.57M	10.85M	11.52M	8.75M	7.07M	7.94M	7.61M	7.08M	391K	-883K	-2.69M	-242K	-52K
Pretax Income	-111.32M	-104.87M	-104.72M	-90.22M	-85.33M	-64.62M	-69.53M	-63.11M	-58.26M	-47.52M	-44.95M	-48.62M	-47.68M	-41.44M	-36.26M	-37.74M	31.2M	-20.06M	-25.08M	-15.65M
Pretax Margin %	-	-	-	-	-	-861.6%	-	-	-	-	-	-	-	-	-	-28588.64%	5820.52%	-228.88%	-671.13%	-192.64%
Income Tax	-585K	-2.57M	538K	677K	-626K	427K	-3.85M	-320K	-333K	412K	-205K	-157K	-220K	290K	1.14M	-587K	40K	-394K	484K	-205K
Effective Tax Rate %	0.53%	2.45%	-0.51%	-0.75%	0.73%	-0.66%	5.53%	0.51%	0.57%	-0.87%	0.46%	0.32%	0.46%	-0.7%	-3.14%	1.56%	0.13%	1.96%	-1.93%	1.31%
Net Income	-110.74M	-102.3M	-105.26M	-90.9M	-84.71M	-65.05M	-65.69M	-62.79M	-57.92M	-47.93M	-44.74M	-48.46M	-47.46M	-41.73M	-37.4M	-37.15M	-31.16M	-19.67M	-25.56M	-15.45M
Net Margin %	-	-	-	-	-	-867.29%	-	-	-	-	-	-	-	-	-	-28143.94%	-5813.06%	-224.39%	-684.08%	-190.12%
Net Income Growth %	-30.73%	-57.27%	-60.25%	-44.76%	-46.24%	-35.71%	-46.81%	-29.57%	-22.05%	-14.87%	-19.65%	-30.45%	-52.32%	-112.14%	-46.28%	-140.53%	-40.93%	-24.78%	-107.45%	-74.42%
Net Income (Continuing)	-110.74M	-102.3M	-105.26M	-90.9M	-84.71M	-65.05M	-65.69M	-62.79M	-57.92M	-47.93M	-44.74M	-48.46M	-47.46M	-41.73M	-37.4M	-37.15M	-31.16M	-19.67M	-25.56M	-15.45M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-1.11	-1.17	-1.31	-1.15	-1.07	-0.83	-0.84	-0.81	-0.75	-0.62	-0.64	-0.73	-0.72	-0.63	-0.57	-0.57	-0.55	-0.36	-0.62	-0.37
EPS Growth %	-3.74%	-40.96%	-55.95%	-41.98%	-42.67%	-33.87%	-31.25%	-10.96%	-4.17%	1.59%	-12.28%	-28.07%	-30.91%	-75%	8.06%	-54.05%	-3.77%	16.28%	-87.88%	-48%
EPS (Basic)	-1.11	-1.17	-1.31	-1.15	-1.07	-0.83	-0.84	-0.81	-0.75	-0.62	-0.64	-0.73	-0.72	-0.63	-0.57	-0.59	-0.55	-0.37	-0.62	-0.37
Diluted Shares Outstanding	99.61M	87.35M	79.25M	79.25M	78.95M	78.69M	78.39M	77.93M	77.67M	77.59M	69.97M	66M	65.86M	65.72M	65.66M	65.47M	56.19M	54.85M	41.19M	42.27M
Basic Shares Outstanding	99.61M	87.35M	79.25M	79.25M	78.95M	78.69M	78.39M	77.93M	77.67M	77.59M	69.97M	66M	65.86M	65.72M	65.66M	62.54M	56.19M	53.06M	41.19M	41.19M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-